Titan Pharmaceuticals rises on plans of merger with undisclosed advanced air mobility player
Titan Pharmaceuticals rises on plans of merger with undisclosed advanced air mobility player
4.49MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8883146065
CUSIP
888314200
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.05
Dividend Share
-
Dividend Yield
-
Earnings Share
-4.61
Wall Street Target Price
7.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
3,000
Gross Profit TTM
-4,365,000
EBITDA
-4,023,750
Profit Margin
0.00%
Return On Assets TTM
-57.20%
Return On Equity TTM
-105.70%
Revenue Per Share TTM
0.004
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-4.61
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
3440.4375
Price Book MRQ
2.3935
Enterprise Value Revenue
7
Enterprise Value EBITDA
0
494.60
2.43%450.31
1.46%585.93
1.01%258.00
0.39%179.39
0.00%151.50
-4.36%299.84
-2.58%108.54
-1.40%92.59
-0.28%78.96
-0.15%